Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations
Kamilla Grønborg Laut(University of Copenhagen), Ole Kirk(University of Copenhagen), Dzmitry Paduta, Elena Kuzovatova, Leah Shepherd(University College London), Dalibor Sedláček(Charles University), Roxana Rădoi(Spitalul Clinic Dr. Victor Babes), János Szlávik(National Center for Epidemiology), Josip Begovać(University of California San Diego), Jelena Šmidt, Gerd Fätkenheuer(University of Cologne), Peré Domingo(Hospital de Sant Pau), Éric Florence(Instituut voor Tropische Geneeskunde), Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Brigitte Schmied, Magnús Gottfreðsson(Reykjavík University), Nikoloz Chkhartishvili(AIDS and Clinical Immunology Research Center), Patrick Schmid(University of St.Gallen), Brygida Knysz(Wroclaw Medical University), Fiona Mulcahy(St. James's Hospital), Matti Ristola(University of Helsinki)
Cited by 19
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k